CRB-913
CANYON-1
Corbus Pharmaceuticals · Phase 1 · Completed · Enrollment 254
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Part 1: PK Lead-in | Obese But Otherwise Healthy Participants | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 low dose | Obese But Otherwise Healthy Participants | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 Medium Dose | Obese But Otherwise Healthy Participants | n/r | n/r | n/r | n/r |
| Part 2: CRB-913 High Dose | Obese But Otherwise Healthy Participants | n/r | n/r | n/r | n/r |
| Part 2: Placebo | Obese But Otherwise Healthy Participants | n/r | n/r | n/r | n/r |